Voice changes following androgenic hormone treatment in women
article
OA: closed
CC0
AI-generated summary
This study found minimal objective vocal changes in ten women treated with Danazol, indicating a need for individualized voice assessments when prescribing androgenic hormones.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Androgenic medications have been known to cause changes to the vocal folds and to voice quality for many decades. One such androgen is Danazol, a synthetic derivative of testosterone. Although altered perceptual voice features have been consistently reported following treatment with Danazol, objective measurements of the voice changes have been limited. The current study incorporates a comprehensive assessment battery of vocal function including instrumental techniques, acoustic analysis and perceptual voice assessment, carried out before, during and after treatment with Danazol in a group of 10 women. The results failed to indicate significant changes in the majority of voice parameters studied. Owing to the variability found in the group results it was clear that the vocal function of women prescribed androgenic hormones needs to be assessed on an individual basis.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (45)
- Action of danazol on plasma lipids and lipoprotein metabolism. via openalex
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- <b>Points</b> : Voice changes after treatment with danazol via openalex
- Effect Of Danazol On Vocal Pitch - A Case-study via openalex
- ETIOLOGY, PREVENTION, AND INHIBITION OF ENDOMETRIOSIS via crossref
- ETIOLOGY, PREVENTION, AND INHIBITION OF ENDOMETRIOSIS via openalex
- ETIOLOGY, PREVENTION, AND INHIBITION OF ENDOMETRIOSIS via openalex
- Goserelin (Zoladex ) depot in the treatment of endometriosis via openalex
- Hormonal therapies for endometriosis: implications for bone metabolism. via openalex
- Incidence of endometriosis in diagnostic laparoscopy. via openalex
- Laparoscopy in the diagnosis and management of endometriosis. via openalex
- The aetiology and pathogenesis of endometriosis via crossref
- The aetiology and pathogenesis of endometriosis via openalex
- Vocal effects of danazol therapy via crossref
- Vocal effects of danazol therapy via openalex
- doi:10.1159/000263216 via crossref
- doi:10.1111/j.1479-828x.1990.tb03232.x via crossref
- doi:10.1016/s0015-0282(16)59765-9 via crossref
- doi:10.1044/jshd.3202.126 via crossref
- doi:10.1136/bmj.287.6401.1308-c via crossref
- doi:10.1097/00007611-195706000-00007 via crossref
- doi:10.1056/nejm198802253180805 via crossref
- doi:10.1016/s0892-1997(88)80028-6 via crossref
- doi:10.1016/s0015-0282(16)55073-0 via crossref
- doi:10.1177/000348948709600423 via crossref
- doi:10.3109/02699059409151021 via crossref
- doi:10.1136/bmj.287.6397.946 via crossref
- doi:10.1111/j.1479-828x.1990.tb03232.x via openalex
- doi:10.1177/000348948709600423 via openalex
- doi:10.1016/s0015-0282(16)59765-9 via openalex
- doi:10.1016/s0015-0282(16)46151-0 via openalex
- doi:10.5694/j.1326-5377.1993.tb121886.x via openalex
- doi:10.1016/0165-5876(90)90331-k via openalex
- doi:10.1111/j.1365-2273.1994.tb01153.x via openalex
- doi:10.1016/s0892-1997(88)80028-6 via openalex
- doi:10.2307/jj.26931941 via openalex
- doi:10.3109/02699059409151021 via openalex
- doi:10.1016/s0892-1997(98)80059-3 via openalex
- doi:10.1016/s0892-1997(99)80005-8 via openalex
- doi:10.1136/bmj.287.6397.946 via openalex
- doi:10.1044/jshd.3202.126 via openalex
- doi:10.1097/00007611-195706000-00007 via openalex
- W2041891139 via openalex
- doi:10.1159/000263216 via openalex
- doi:10.1016/s0892-1997(99)80005-8 via crossref
Source provenance
- crossref
- last seen: 2026-05-10T19:04:07.457109+00:00
- openalex
- last seen: 2026-05-10T10:26:51.820283+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK